Australia markets closed

SynAct Pharma AB (8F8.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.5880-0.0005 (-0.08%)
As of 09:59AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Gross profit
0
0
0
0
-
Operating expenses
Research development
105,055
105,055
70,067
60,490
22,788
Selling general and administrative
44,826
44,826
35,611
16,225
8,811
Total operating expenses
149,840
149,840
105,573
76,715
31,285
Operating income or loss
-149,840
-149,840
-105,573
-76,715
-31,285
Interest expense
797
797
294
105
39
Income before tax
-224,275
-224,275
-107,066
-76,809
-31,304
Income tax expense
-8,466
-8,466
-7,860
-7,505
-4,753
Income from continuing operations
-215,809
-215,809
-99,206
-69,304
-26,551
Net income
-215,810
-215,810
-99,205
-69,304
-26,551
Net income available to common shareholders
-215,810
-215,810
-99,205
-69,304
-26,551
Basic EPS
-5.04
-6.64
-3.60
-2.68
-1.18
Diluted EPS
-5.04
-6.64
-3.60
-2.68
-1.18
Basic average shares
30,905
32,524
27,585
25,848
22,556
Diluted average shares
30,905
32,524
27,585
25,848
22,556